University of Cambridge > Talks.cam > PDG Seminars (Pathogen Dynamics Group) > Correlates of protection of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infections

  Browse A-Z

Log in

University Account External (via Google)

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹī¸ Information

Correlates of protection of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infections

Download to your calendar using vCal

If you have a question about this talk, please contact Theodora Anderson .

For Zoom details please e-mail: pdgcambridge@gmail.com

: Understanding the relationship between immune response to SARS -CoV-2 vaccines and protection against clinical outcomes is urgently needed to facilitate further vaccine development. However, evidence on correlates of protection from SARS -CoV-2 vaccine trials is limited. Using phase II/III ChAdOx1 nCoV-19 vaccine trial data in the UK, we estimated the correlates of protection by immune markers against symptomatic COVID -19 disease using a case-cohort study design. Our preliminary analysis found higher immune marker levels are associated with lower risk of symptomatic disease and in particular lower risk of lower respiratory tract infections.

This talk is part of the PDG Seminars (Pathogen Dynamics Group) series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Cambridge University Engineering Department, LR3 Lord Colyton Hall, Gonville & Caius College Centre of African Studies and the Department of the History and Philosophy of Science

Other talks

Transparency, Diversity, and Equality in Music Psychology: A Meta-Science Perspective Tea and Coffee Break Formalising mathematics and spectral geometry in Lean Title to be confirmed Tea and Coffee Break The organisational management of traumatic stress
 

Š 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity